Literature DB >> 30367202

Evaluation of six-minute walk test in juvenile systemic sclerosis.

Oya Koker1, Amra Adrovic2, Sezgin Sahin2, Mehmet Yildiz2, Kenan Barut2, Rukiye Eker Omeroglu1, Ozgur Kasapcopur3.   

Abstract

The objective is to evaluate the walking distance and oxygen desaturation during the six-minute walk test and to establish correlations between the test results and other clinical findings so to assess the reliability of the test for evaluation of children with juvenile systemic sclerosis (jSSc). A total of 25 jSSc, 27 juvenile systemic lupus erythematosus (jSLE), and 30 healthy controls were included. The test is conducted according to the guidelines recommended by the American Thoracic Society, standardized in 2002. Median values of walking distances were 470 (415-580) m in jSSc; 518 (376-618) m in jSLE; and 562 (493.5-618) m in healthy controls. jSSc patients walked significantly less distance comparing to controls (p < 0.001). jSSc patients with lung involvement walked less than those without lung involvement [463.2 (418-565) m vs. 491.5 (415-580) m], but without a significant difference (p = 0.82). The frequency of lower extremity pain during and after the test was significantly higher in the jSSc cohort compared to both control groups (p = 0.001). Patients with myalgia were found to walk less than those without myalgia [446.5 (415-538) m vs. 493.5 (428-580) m] (p = 0.04). Patients with jSSc have limited walking distances. Despite the decreased walking distance among jSSc patients with ILD and/or PAH, the limited number of patients makes the results inappropriate for interpretation. Low extremity pain influences the walking capacity of jSSc patients.

Entities:  

Keywords:  Interstitial lung disease; Pediatric systemic sclerosis; Pulmonary arterial hypertension; Six-minute walk test

Mesh:

Substances:

Year:  2018        PMID: 30367202     DOI: 10.1007/s00296-018-4185-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  The six-minute walk test in healthy children: reliability and validity.

Authors:  A M Li; J Yin; C C W Yu; T Tsang; H K So; E Wong; D Chan; E K L Hon; R Sung
Journal:  Eur Respir J       Date:  2005-06       Impact factor: 16.671

2.  The 6-minute walk test in scleroderma--how measuring everything measures nothing.

Authors:  A J Impens; S Wangkaew; J R Seibold
Journal:  Rheumatology (Oxford)       Date:  2008-10       Impact factor: 7.580

3.  Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.

Authors:  Katrin Deuschle; Katharina Weinert; Mike O Becker; Marina Backhaus; Dörte Huscher; Gabriela Riemekasten
Journal:  Clin Exp Rheumatol       Date:  2011-05-13       Impact factor: 4.473

Review 4.  Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Authors:  Els Vandecasteele; Michel De Pauw; Filip De Keyser; Saskia Decuman; Ellen Deschepper; Yves Piette; Guy Brusselle; Vanessa Smith
Journal:  Int J Cardiol       Date:  2016-03-25       Impact factor: 4.164

5.  Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension.

Authors:  Johannes M Douwes; Anneke K Hegeman; Merel B van der Krieke; Marcus T R Roofthooft; Hans L Hillege; Rolf M F Berger
Journal:  Int J Cardiol       Date:  2015-08-28       Impact factor: 4.164

6.  A preliminary disease severity score for juvenile systemic sclerosis.

Authors:  Francesco La Torre; Giorgia Martini; Ricardo Russo; Maria Marta Katsicas; Fabrizia Corona; Giuseppina Calcagno; Fernanda Falcini; Fabio Vittadello; Francesco Zulian
Journal:  Arthritis Rheum       Date:  2012-12

7.  The influence of PaO2, pH and SaO2 on maximal oxygen uptake.

Authors:  H B Nielsen; P Madsen; L B Svendsen; R C Roach; N H Secher
Journal:  Acta Physiol Scand       Date:  1998-09

8.  Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.

Authors:  Margaret C Garin; Kristin B Highland; Richard M Silver; Charlie Strange
Journal:  J Rheumatol       Date:  2009-01-22       Impact factor: 4.666

9.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

10.  Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Authors:  Sébastien Peytrignet; Christopher P Denton; Mark Lunt; Roger Hesselstrand; Luc Mouthon; Alan Silman; Xiaoyan Pan; Edith Brown; László Czirják; Jörg H W Distler; Oliver Distler; Kim Fligelstone; William J Gregory; Rachel Ochiel; Madelon Vonk; Codrina Ancuta; Voon H Ong; Dominique Farge; Marie Hudson; Marco Matucci-Cerinic; Alexandra Balbir-Gurman; Øyvind Midtvedt; Alison C Jordan; Wendy Stevens; Pia Moinzadeh; Frances C Hall; Christian Agard; Marina E Anderson; Elisabeth Diot; Rajan Madhok; Mohammed Akil; Maya H Buch; Lorinda Chung; Nemanja Damjanov; Harsha Gunawardena; Peter Lanyon; Yasmeen Ahmad; Kuntal Chakravarty; Søren Jacobsen; Alexander J MacGregor; Neil McHugh; Ulf Müller-Ladner; Gabriela Riemekasten; Michael Becker; Janet Roddy; Patricia E Carreira; Anne Laure Fauchais; Eric Hachulla; Jennifer Hamilton; Murat Inanç; John S McLaren; Jacob M van Laar; Sanjay Pathare; Susanna Proudman; Anna Rudin; Joanne Sahhar; Brigitte Coppere; Christine Serratrice; Tom Sheeran; Douglas J Veale; Claire Grange; Georges-Selim Trad; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.